Optaflexx™and Monovet® and Tylan™

Veterinary medicine · U.S. Food and Drug Administration, Center for Veterinary Medicine · United States

  • Animal drug application 200646
  • Animal drug product ID 8716

What the source publishes

Holder
Huvepharma EOOD
Active ingredients
Monensin Ractopamine Hydrochloride Tylosin Phosphate
Form
Type A medicated articles for use in the manufacture of Type B and Type C medicated feeds
Routes
Oral
Supply regime
VFD

Names this record is found by

Complete source data
us:fda:animaldrugs:6483:8716
{
  "form": "Type A medicated articles for use in the manufacture of Type B and Type C medicated feeds",
  "name": "Optaflexx™and Monovet® and Tylan™",
  "holder": "Huvepharma EOOD",
  "routes": [
    "Oral"
  ],
  "smpcUrl": null,
  "marketed": null,
  "useDomain": "veterinary",
  "leafletUrl": null,
  "supplyRegime": "VFD",
  "nativeProduct": {
    "routes": [
      "Oral"
    ],
    "species": {
      "Cattle:408": "Fed in confinement for slaughter"
    },
    "sortOrder": 1,
    "withdrawals": [
      "<p>A withdrawal time has not been established for pre-ruminating calves. Do not use in calves to be processed for veal.</p><p></p>"
    ],
    "doseFormName": "Type A medicated articles for use in the manufacture of Type B and Type C medicated feeds",
    "applicationId": null,
    "specifications": "Optaflexx™: 45.4 g/lb (100 g/kg) of ractopamine hydrochloride, Monovet®: 90.7 g/lb of monensin, and Tylan™: 40 g/lb and 100g/lb of tylosin",
    "proprietaryName": "Optaflexx™and Monovet® and Tylan™",
    "proprietaryNameId": 8716,
    "statusDescription": "VFD"
  },
  "nativeSummary": {
    "noohDate": null,
    "publishDate": "2020-02-21",
    "sponsorName": "Huvepharma EOOD",
    "applicationId": 6483,
    "applicationType": "A",
    "proprietaryName": "Optaflexx™and Monovet® and Tylan™\n",
    "applicationNumber": 200646,
    "activeIngredientName": "Monensin\nRactopamine Hydrochloride\nTylosin Phosphate\n",
    "applicationStatusCode": "A",
    "applicationStatusValue": null,
    "voluntaryWithdrawalDate": null
  },
  "targetSpecies": [
    {
      "code": "408",
      "label": "Cattle",
      "native": {
        "key": "Cattle:408",
        "population": "Fed in confinement for slaughter"
      },
      "sourceId": "us.fda.animal-drugs",
      "population": "Fed in confinement for slaughter",
      "canonicalId": "cattle",
      "mappingStatus": "mapped",
      "mappingVersion": 1
    }
  ],
  "informationUrl": "https://animaldrugsatfda.fda.gov/adafda/views/#/search",
  "ingredientScope": "application-level; no product-specific composition inferred",
  "nativePublishDate": "2020-02-21",
  "sourceDisposition": "reviewed-veterinary-application-product",
  "useDomainEvidence": {
    "basis": "publisher-dataset-scope",
    "field": "sourceId",
    "value": "us.fda.animal-drugs",
    "version": 1,
    "sourceId": "us.fda.animal-drugs"
  },
  "withdrawalPeriods": [
    {
      "native": "<p>A withdrawal time has not been established for pre-ruminating calves. Do not use in calves to be processed for veal.</p><p></p>",
      "status": "unparsed"
    }
  ],
  "patientEligibility": "not-assessed",
  "nativeApplicationId": 6483,
  "targetSpeciesStatus": "reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "activeIngredientsText": "Monensin\nRactopamine Hydrochloride\nTylosin Phosphate\n",
  "nativeApplicationType": "A",
  "applicationIngredients": [
    {
      "activeIngredientName": "Ractopamine Hydrochloride",
      "activeIngredientTolerance": "The tolerance for ractopamine hydrochloride (the marker residue) in swine is 0.15 part per million) in liver (target tissue).<P>\r\n\r\nThe tolerance for ractopamine hydrochloride (the marker residue) in cattle is 0.03 part per million in muscle and 0.09 part per million in liver.<P>\r\n\r\nThe tolerance for ractopamine hydrochloride (the marker residue) in turkeys is 0.45 ppm in liver(target tissue) and 0.1 ppm in muscle.<P>\r\n\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t"
    },
    {
      "activeIngredientName": "Monensin",
      "activeIngredientTolerance": "<p>A tolerance of 0.05 part per million is established for negligible residues of monensin in the edible tissues of cattle and goats. A tolerance for residues of monensin in chickens, turkeys and quail is not needed.</p>"
    },
    {
      "activeIngredientName": "Tylosin Phosphate",
      "activeIngredientTolerance": "<p>Tolerances are established for residues of tylosin in edible products of animals as follows:     a.  Chickens and turkeys: 0.2 part per million (negligible residue) in uncooked fat, muscle, liver, and kidney.     b.  Cattle: 0.2 part per million (negligible residue) in uncooked fat, muscle, liver, and kidney.     c.   Swine: 0.2 part per million (negligible residue) in uncooked fat, muscle, liver, and kidney.     d.   Milk: 0.05 part per million (negligible residue).     e.   Eggs: 0.2 part per million (negligible residue).</p>"
    }
  ],
  "nativeApplicationNumber": 200646,
  "nativeProprietaryNameId": 8716,
  "restrictionObservations": [
    {
      "indicationText": "<p><font size=\"2\"></font></p><p>For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. </p>",
      "limitationText": null,
      "populationText": "Cattle fed in confinement for slaughter"
    },
    {
      "indicationText": "<p>For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to <em>Eimeria bovis </em>and <em>E. zuernii </em>and reduction of<br/>incidence of liver abscesses caused by <em>Fusobacterium necrophorum</em> and <em>Arcanobacterium</em> (<em>Actinomyces</em>) <em>pyogenes</em> in cattle fed in confinement for<br/>slaughter for the last 28 to 42 days on feed.<br/></p>",
      "limitationText": null,
      "populationText": "Cattle fed in confinement for slaughter"
    },
    {
      "indicationText": "<p>For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to <em>Eimeria bovis </em>and <em>E.<br/>zuernii </em>and reduction of incidence of liver abscesses caused by <em>Fusobacterium necrophorum and Arcanobacterium </em>(<em>Actinomyces</em>) <em>pyogenes</em> in cattle fed in<br/>confinement for slaughter for the last 28 to 42 days on feed.<br/></p>",
      "limitationText": null,
      "populationText": "Cattle fed in confinement for slaughter"
    }
  ],
  "withdrawalPeriodsStatus": "reported-unparsed",
  "publisherIdentityMeaning": "applicationId/proprietaryNameId are technical website keys; applicationNumber is a separate FDA application reference",
  "nativeNoticeOfHearingDate": null,
  "nativeApplicationStatusCode": "A",
  "nativeVoluntaryWithdrawalDate": null
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.animal-drugs" \
  --data-urlencode "id=us:fda:animaldrugs:6483:8716"